Skip to search formSkip to main contentSkip to account menu

MS 209

Known as: MS-209, MS209 
National Institutes of Health

Related topics

Related topics

2 relations
Dofequidar Fumarate

Broader (1)

dofequidar

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Phase ICombining a P-Glycoprotein Inhibitor , MS 209 , in Combinationwith Docetaxel in Patients with AdvancedMalignancies
Purpose:The purpose of this study was to investigate the safety and tolerability of MS209, a potent inhibitor of P-glycoprotein… 
2002
2002
MS-209 enhances bioavailability of orally administered paclitaxel
  • 2002
  • Corpus ID: 195143807
1994
1994
Modulation of multidrug resistance in experimental tumor models with dexverapamil and MS-209: 86
1994
1994
Potentiation of adriamycin anti-tumor activity by MS-209 in murine colon 26 tumor: 79
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)